{{expand|time=2014-03-10T00:38:05+00:00}}
{{unreferenced|time=2014-03-10T00:38:05+00:00}}{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 407062079
| IUPAC_name = 
| image = EnoxaparinSodium.png
| image2 = Enoxaparin sodium ball-and-stick.png
| width = 300px

<!--Clinical data-->
| tradename = Lovenox, Clexane
| Drugs.com = {{drugs.com|monograph|enoxaparin_sodium}}
| MedlinePlus = a696006
| pregnancy_category = B
| legal_UK = POM
| legal_US = Rx-only
| legal_status = 
| routes_of_administration = Subcutaneous (SC) Injection and intravenous (IV) per package insert
| licence_US = enoxaparin

<!--Pharmacokinetic data-->
| bioavailability = 92%
| protein_bound = 80% bound-albumin
| metabolism = primarily by kidneys
| elimination_half-life = 4.5 hours

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 9005-49-6
| ATC_prefix = B01
| ATC_suffix = AB05
| ATC_supplemental = 
| PubChem = 772
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
 | DrugBank = DB01225
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = NA
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 8NZ41MIK1O
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07510
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201685

<!--Chemical data-->
| chemical_formula = (C<sub>26</sub>H<sub>40</sub>N<sub>2</sub>O<sub>36</sub>S<sub>5</sub>)n
| molecular_weight = 4500 [[Dalton_(unit)|daltons]] (average)
}}
'''依诺肝素'''（商品名Lovenox、Xaparin和Clexane）是一种[[低分子量肝素|低分子量肝素]]。它是一种用于预防和治疗深静脉血栓或肺栓塞的抗凝血剂，其用法为皮下注射（由卫生保健提供者或患者）。

{{抗血栓药}}

[[Category:肝素|Category:肝素]]
[[Category:赛诺菲|Category:赛诺菲]]